Reports and Briefs on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview

Analysis of socio-demographic and economic trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
13 Apr 2011 $1520
Buy
Report
Report

Pharmaceutical Key Trends 2011: Generics Market Overview

Analysis on the global generics market. It includes an overview of drivers and resistors to generic uptake, key generics players, and opportunities for the generics industry.

Published By Datamonitor
18 Apr 2011 $2800
Buy
Report
Report

Dainippon Sumitomo Ph. Co., Ltd: PharmaVitae Report

Analysis of Dainippon Sumitomo's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 May 2011 $2800
Buy
Report
Report

Genzyme Corporation: PharmaVitae Report

Analysis of Genzyme's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 May 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

Global analysis of socio-demographic and economic trends, rising healthcare costs, intensifying cost-containment and regulatory pressures, the patent cliff as well insight into the pharmaceutical industry’s strategic responses to drive profitability.

Published By Datamonitor
20 May 2011 $1520
Buy
Report
Report

F. Hoffmann-La Roche Ltd: PharmaVitae Report

Analysis of Roche's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 Jun 2011 $2800
Buy
Report
Report

Cephalon Inc.: PharmaVitae Report

Analysis of Cephalon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
10 Jun 2011 $2800
Buy
Report
Report

Amgen Inc.: PharmaVitae Report

Analysis of Amgen's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Jun 2011 $2800
Buy
Report
Report

Forest Laboratories Inc.: PharmaVitae Report

Analysis of Forest's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Sanofi: PharmaVitae Report

Analysis of Sanofi corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.